The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Targeting Bruton's tyrosine kinase in B cell malignancies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. (2000) · Nature · doi:10.1038/35000501 · Cited by 9,925
Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
Byrd, J. C., Furman, R. R., Coutre, S. E., Flinn, I. W., Burger, J. A., Blum, K. A., Grant, B., Sharman, J. P., Coleman, M., Wierda, W. G., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215637 · Cited by 2,270
Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma
Wang, M. L., Rule, S., Martin, P., Goy, A., Auer, R., Kahl, B. S., Jurczak, W., Advani, R. H., Romaguera, J. E., Williams, M. E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1306220 · Cited by 1,685
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
Davis, R. E., Ngo, V. N., Lenz, G., Tolar, P., Young, R. M., Romesser, P. B., Kohlhammer, H., Lamy, L., Zhao, H., Yang, Y., et al. (2010) · Nature · doi:10.1038/nature08638 · Cited by 1,643
Honigberg, L. A., Smith, A. M., Sirisawad, M., Verner, E., Loury, D., Chang, B., Li, S., Pan, Z., Thamm, D. H., Miller, R. A., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004594107 · Cited by 1,561
Oncogenically active MYD88 mutations in human lymphoma
Ngo, V. N., Young, R. M., Schmitz, R., Jhavar, S., Xiao, W., Lim, K.-H., Kohlhammer, H., Xu, W., Yang, Y., Zhao, H., et al. (2011) · Nature · doi:10.1038/nature09671 · Cited by 1,512
Vetrie, D., Vořechovský, I., Sideras, P., Holland, J., Davies, A., Flinter, F., Hammarström, L., Kinnon, C., Levinsky, R., Bobrow, M., et al. (1993) · Nature · doi:10.1038/361226a0 · Cited by 1,461
Initial genome sequencing and analysis of multiple myeloma
Chapman, M. A., Lawrence, M. S., Keats, J. J., Cibulskis, K., Sougnez, C., Schinzel, A. C., Harview, C. L., Brunet, J.-P., Ahmann, G. J., Adli, M., et al. (2011) · Nature · doi:10.1038/nature09837 · Cited by 1,433
Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia
Tsukada, S., Saffran, D. C., Rawlings, D. J., Parolini, O., Allen, R. C., Klisak, I., Sparkes, R. S., Kubagawa, H., Mohandas, T., Quan, S., et al. (1993) · Cell · doi:10.1016/0092-8674(93)90667-f · Cited by 1,327
MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
Treon, S. P., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Sheehy, P., Manning, R. J., Patterson, C. J., Tripsas, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200710 · Cited by 1,294
Advani, R. H., Buggy, J. J., Sharman, J. P., Smith, S. M., Boyd, T. E., Grant, B., Kolibaba, K. S., Furman, R. R., Rodriguez, S., Chang, B. Y., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.7906 · Cited by 1,128
Davis, R. E., Brown, K. D., Siebenlist, U., & Staudt, L. M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.12.1861 · Cited by 1,051
Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
Compagno, M., Lim, W. K., Grunn, A., Nandula, S. V., Brahmachary, M., Shen, Q., Bertoni, F., Ponzoni, M., Scandurra, M., Califano, A., et al. (2009) · Nature · doi:10.1038/nature07968 · Cited by 1,038
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
Keats, J. J., Fonseca, R., Chesi, M., Schop, R., Baker, A., Chng, W.-J., Van Wier, S., Tiedemann, R., Shi, C.-X., Sebag, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.003 · Cited by 983
Annunziata, C. M., Davis, R. E., Demchenko, Y., Bellamy, W., Gabrea, A., Zhan, F., Lenz, G., Hanamura, I., Wright, G., Xiao, W., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.004 · Cited by 952
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P. G., & Anderson, K. C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2189 · Cited by 932
Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma
Lenz, G., Davis, R. E., Ngo, V. N., Lam, L., George, T. C., Wright, G. W., Dave, S. S., Zhao, H., Xu, W., Rosenwald, A., et al. (2008) · Science · doi:10.1126/science.1153629 · Cited by 867
Mutation of Unique Region of Bruton's Tyrosine Kinase in Immunodeficient XID Mice
Rawlings, D. J., Saffran, D. C., Tsukada, S., Largaespada, D. A., Grimaldi, J. C., Cohen, L., Mohr, R. N., Bazan, J. F., Howard, M., Copeland, N. G., et al. (1993) · Science · doi:10.1126/science.8332901 · Cited by 856
Monti, S. (2005) · Blood · doi:10.1182/blood-2004-07-2947 · Cited by 820
Herishanu, Y., Pérez-Galán, P., Liu, D., Biancotto, A., Pittaluga, S., Vire, B., Gibellini, F., Njuguna, N., Lee, E., Stennett, L., et al. (2011) · Blood · doi:10.1182/blood-2010-05-284984 · Cited by 815
Dubovsky, J. A., Beckwith, K. A., Natarajan, G., Woyach, J. A., Jaglowski, S., Zhong, Y., Hessler, J. D., Liu, T.-M., Chang, B. Y., Larkin, K. M., et al. (2013) · Blood · doi:10.1182/blood-2013-06-507947 · Cited by 810
Herman, S. E. M., Gordon, A. L., Hertlein, E., Ramanunni, A., Zhang, X., Jaglowski, S., Flynn, J., Jones, J., Blum, K. A., Buggy, J. J., et al. (2011) · Blood · doi:10.1182/blood-2011-01-328484 · Cited by 807
Defective B cell development and function in Btk-deficient mice
Khan, W. N., Alt, F. W., Gerstein, R. M., Malynn, B. A., Larsson, I., Rathbun, G., Davidson, L., Müller, S., Kantor, A. B., Herzenberg, L. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90114-0 · Cited by 726
Ponader, S., Chen, S.-S., Buggy, J. J., Balakrishnan, K., Gandhi, V., Wierda, W. G., Keating, M. J., O'Brien, S., Chiorazzi, N., & Burger, J. A. (2012) · Blood · doi:10.1182/blood-2011-10-386417 · Cited by 640
X-Linked Agammaglobulinemia: Report on a United States Registry of 201 Patients
Winkelstein, J. A., Marino, M. C., Lederman, H. M., Jones, S. M., Sullivan, K., Burks, A. W., Conley, M. E., Cunningham-Rundles, C., & Ochs, H. D. (2006) · Medicine · doi:10.1097/01.md.0000229482.27398.ad · Cited by 639
Colocalization of X-Linked Agammaglobulinemia and X-Linked Immunodeficiency Genes
Thomas, J. D., Sideras, P., Smith, C. I. E., Vořechovský, I., Chapman, V., & Paul, W. E. (1993) · Science · doi:10.1126/science.8332900 · Cited by 613
A loss-of-function RNA interference screen for molecular targets in cancer
Ngo, V. N., Davis, R. E., Lamy, L., Yu, X., Zhao, H., Lenz, G., Lam, L. T., Dave, S., Yang, L., Powell, J., et al. (2006) · Nature · doi:10.1038/nature04687 · Cited by 605
de Rooij, M. F. M., Kuil, A., Geest, C. R., Eldering, E., Chang, B. Y., Buggy, J. J., Pals, S. T., & Spaargaren, M. (2012) · Blood · doi:10.1182/blood-2011-11-390989 · Cited by 554
Genetic heterogeneity of diffuse large B-cell lymphoma
Zhang, J., Grubor, V., Love, C. L., Banerjee, A., Richards, K. L., Mieczkowski, P. A., Dunphy, C., Choi, W., Au, W. Y., Srivastava, G., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205299110 · Cited by 527
Fu (1998) · doi:10.1016/s1074-7613(00)80591-9 · Cited by 518
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
Minden, M. D.-V., Übelhart, R., Schneider, D., Wossning, T., Bach, M. P., Buchner, M., Hofmann, D., Surova, E., Follo, M., Köhler, F., et al. (2012) · Nature · doi:10.1038/nature11309 · Cited by 504
Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)–dependent migration and homing in multiple myeloma
Alsayed, Y., Ngo, H., Runnels, J., Leleu, X., Singha, U. K., Pitsillides, C. M., Spencer, J. A., Kimlinger, T., Ghobrial, J. M., Jia, X., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035857 · Cited by 478
O'Brien, S., Furman, R. R., Coutre, S. E., Sharman, J. P., Burger, J. A., Blum, K. A., Grant, B., Richards, D. A., Coleman, M., Wierda, W. G., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70513-8 · Cited by 466
Activation of BTK by a Phosphorylation Mechanism Initiated by SRC Family Kinases
Rawlings, D. J., Scharenberg, A. M., Park, H., Wahl, M. I., Lin, S., Kato, R. M., Fluckiger, A.-C., Witte, O. N., & Kinet, J.-P. (1996) · Science · doi:10.1126/science.271.5250.822 · Cited by 445
Molecular pathogenesis of mantle cell lymphoma
Jares, P., Colomer, D., & Campo, E. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61272 · Cited by 382
Mathews Griner, L. A., Guha, R., Shinn, P., Young, R. M., Keller, J. M., Liu, D., Goldlust, I. S., Yasgar, A., McKnight, C., Boxer, M. B., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311846111 · Cited by 377
Yang, G., Zhou, Y., Liu, X., Xu, L., Cao, Y., Manning, R. J., Patterson, C. J., Buhrlage, S. J., Gray, N., Tai, Y.-T., et al. (2013) · Blood · doi:10.1182/blood-2012-12-475111 · Cited by 352
Specific Btk inhibition suppresses B cell- and myeloid cell-mediated arthritis
Di Paolo, J. A., Huang, T., Balazs, M., Barbosa, J., Barck, K. H., Bravo, B. J., Carano, R. A. D., Darrow, J., Davies, D. R., DeForge, L. E., et al. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.481 · Cited by 340
Integration of B cell responses through Toll-like receptors and antigen receptors
Rawlings, D. J., Schwartz, M. A., Jackson, S. W., & Meyer-Bahlburg, A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3190 · Cited by 339
Rahal, R., Frick, M., Romero, R., Korn, J. M., Kridel, R., Chun Chan, F., Meissner, B., Bhang, H.-E., Ruddy, D., Kauffmann, A., et al. (2014) · Nature Medicine · doi:10.1038/nm.3435 · Cited by 334
Molecular pathogenesis of multiple myeloma and its premalignant precursor
Kuehl, W. M., & Bergsagel, P. L. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61188 · Cited by 334
Amplification of B cell antigen receptor signaling by a Syk/ITAM positive feedback loop
Rolli, V., Gallwitz, M., Wossning, T., Flemming, A., Schamel, W. W. A., Zürn, C., & Reth, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00739-6 · Cited by 331
Regulation of Btk Function by a Major Autophosphorylation Site Within the SH3 Domain
Park, H., Wahl, M. I., Afar, D. E. H., Turck, C. W., Rawlings, D. J., Tam, C., Scharenberg, A. M., Kinet, J.-P., & Witte, O. N. (1996) · Immunity · doi:10.1016/s1074-7613(00)80417-3 · Cited by 323
Tyrosine Kinases Btk and Tec Regulate Osteoclast Differentiation by Linking RANK and ITAM Signals
Shinohara, M., Koga, T., Okamoto, K., Sakaguchi, S., Arai, K., Yasuda, H., Takai, T., Kodama, T., Morio, T., Geha, R. S., et al. (2008) · Cell · doi:10.1016/j.cell.2007.12.037 · Cited by 321
Chen, L., Monti, S., Juszczynski, P., Daley, J., Chen, W., Witzig, T. E., Habermann, T. M., Kutok, J. L., & Shipp, M. A. (2008) · Blood · doi:10.1182/blood-2007-07-100115 · Cited by 316
Smith, C. I. E., Baskin, B., Humire-Greiff, P., Zhou, J. N., Olsson, P. G., Maniar, H. S., Kjellén, P., Lambris, J. D., Christensson, B., Hammarström, L., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.2.557 · Cited by 305
Koopman, G., Keehnen, R. M. J., Lindhout, E., Newman, W., Shimizu, Y., van Seventer, G. A., de Groot, C., & Pals, S. T. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.152.8.3760 · Cited by 303
Petro, J. B., Rahman, S. M. J., Ballard, D. W., & Khan, W. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1745 · Cited by 301
Huck, K., Feyen, O., Niehues, T., Rüschendorf, F., Hübner, N., Laws, H.-J., Telieps, T., Knapp, S., Wacker, H.-H., Meindl, A., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37901 · Cited by 294
Jefferies, C. A., Doyle, S., Brunner, C., Dunne, A., Brint, E., Wietek, C., Walch, E., Wirth, T., & O'Neill, L. A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301484200 · Cited by 292
Okada, T., Maeda, A., Iwamatsu, A., Gotoh, K., & Kurosaki, T. (2000) · Immunity · doi:10.1016/s1074-7613(00)00079-0 · Cited by 286
de Gorter, D. J. J., Beuling, E. A., Kersseboom, R., Middendorp, S., van Gils, J. M., Hendriks, R. W., Pals, S. T., & Spaargaren, M. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.012 · Cited by 285
Self-citationThe Btk tyrosine kinase is a major target of the Bcr-Abl inhibitor dasatinib
Hantschel, O., Rix, U., Schmidt, U., Bürckstümmer, T., Kneidinger, M., Schütze, G., Colinge, J., Bennett, K. L., Ellmeier, W., Valent, P., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702654104 · Cited by 284
Woyach, J. A., Smucker, K., Smith, L. L., Lozanski, A., Zhong, Y., Ruppert, A. S., Lucas, D., Williams, K., Zhao, W., Rassenti, L., et al. (2014) · Blood · doi:10.1182/blood-2013-09-527853 · Cited by 280
Chaturvedi, A., Dorward, D., & Pierce, S. K. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.019 · Cited by 272
Gauthier, L., Rossi, B., Roux, F., Termine, E., & Schiff, C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202323999 · Cited by 268
Liu, X., Zhan, Z., Li, D., Xu, L., Ma, F., Zhang, P., Yao, H., & Cao, X. (2011) · Nature Immunology · doi:10.1038/ni.2015 · Cited by 261
The Src, Syk, and Tec family kinases: Distinct types of molecular switches
Bradshaw, J. M. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.001 · Cited by 256
Saouaf, S. J., Mahajan, S., Rowley, R. B., Kut, S. A., Fargnoli, J., Burkhardt, A. L., Tsukada, S., Witte, O. N., & Bolen, J. B. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.20.9524 · Cited by 242
Hyvonen, M. (1997) · The EMBO Journal · doi:10.1093/emboj/16.12.3396 · Cited by 239
Tsukada, S., Simon, M. I., Witte, O. N., & Katz, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.11256 · Cited by 238
Guo, B., Kato, R. M., Garcia-Lloret, M., Wahl, M. I., & Rawlings, D. J. (2000) · Immunity · doi:10.1016/s1074-7613(00)00024-8 · Cited by 229
Muzio, M., Apollonio, B., Scielzo, C., Frenquelli, M., Vandoni, I., Boussiotis, V., Caligaris-Cappio, F., & Ghia, P. (2008) · Blood · doi:10.1182/blood-2007-09-111344 · Cited by 228
The B Cell Antigen Receptor Controls Integrin Activity through Btk and PLCγ2
Spaargaren, M., Beuling, E. A., Rurup, M. L., Meijer, H. P., Klok, M. D., Middendorp, S., Hendriks, R. W., & Pals, S. T. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20011866 · Cited by 228
Self-citationIan Mockridge, C., Potter, K. N., Wheatley, I., Neville, L. A., Packham, G., & Stevenson, F. K. (2007) · Blood · doi:10.1182/blood-2006-11-056648 · Cited by 227
Evans, E. K., Tester, R., Aslanian, S., Karp, R., Sheets, M., Labenski, M. T., Witowski, S. R., Lounsbury, H., Chaturvedi, P., Mazdiyasni, H., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.203489 · Cited by 220
BTK Regulates PtdIns-4,5-P2 Synthesis
Saito, K., Tolias, K. F., Saci, A., Koon, H. B., Humphries, L. A., Scharenberg, A., Rawlings, D. J., Kinet, J.-P., & Carpenter, C. L. (2003) · Immunity · doi:10.1016/s1074-7613(03)00297-8 · Cited by 211
Kil, L. P., de Bruijn, M. J. W., van Nimwegen, M., Corneth, O. B. J., van Hamburg, J. P., Dingjan, G. M., Thaiss, F., Rimmelzwaan, G. F., Elewaut, D., Delsing, D., et al. (2012) · Blood · doi:10.1182/blood-2011-12-397919 · Cited by 209
Self-citationBruton's Tyrosine Kinase Links the B Cell Receptor to Nuclear Factor κb Activation
Bajpai, U. D., Zhang, K., Teutsch, M., Sen, R., & Wortis, H. H. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.10.1735 · Cited by 208
Severe B Cell Deficiency in Mice Lacking the Tec Kinase Family Members Tec and Btk
Ellmeier, W., Jung, S., Sunshine, M. J., Hatam, F., Xu, Y., Baltimore, D., Mano, H., & Littman, D. R. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.11.1611 · Cited by 205
Chang, B. Y., Francesco, M., De Rooij, M. F. M., Magadala, P., Steggerda, S. M., Huang, M. M., Kuil, A., Herman, S. E. M., Chang, S., Pals, S. T., et al. (2013) · Blood · doi:10.1182/blood-2013-02-482125 · Cited by 203
de Weers, M., Verschuren, M. C. M., Kraakman, M. E. M., Mensink, R. G. J., Schuurman, R. K. B., van Dongen, J. J. M., & Hendriks, R. W. (1993) · European Journal of Immunology · doi:10.1002/eji.1830231210 · Cited by 202
Self-citationHashimoto, A., Okada, H., Jiang, A., Kurosaki, M., Greenberg, S., Clark, E. A., & Kurosaki, T. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.7.1287 · Cited by 199
BTKbase: the mutation database for X-linked agammaglobulinemia
Väliaho, J., Smith, C. I. E., & Vihinen, M. (2006) · Human Mutation · doi:10.1002/humu.20410 · Cited by 196
Rinaldi, A., Kwee, I., Taborelli, M., Largo, C., Uccella, S., Martin, V., Poretti, G., Gaidano, G., Calabrese, G., Martinelli, G., et al. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05883.x · Cited by 195
Mahajan, S., Ghosh, S., Sudbeck, E. A., Zheng, Y., Downs, S., Hupke, M., & Uckun, F. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9587 · Cited by 191
Aoki, Y., Isselbacher, K. J., & Pillai, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10606 · Cited by 190
The G protein Gα12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain
Jiang, Y., Ma, W., Wan, Y., Kozasa, T., Hattori, S., & Huang, X.-Y. (1998) · Nature · doi:10.1038/27454 · Cited by 186
Li, T., Tsukada, S., Satterthwaite, A., Havlik, M. H., Park, H., Takatsu, K., & Witte, O. N. (1995) · Immunity · doi:10.1016/1074-7613(95)90026-8 · Cited by 186
The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion
Flemming, A., Brummer, T., Reth, M., & Jumaa, H. (2003) · Nature Immunology · doi:10.1038/ni862 · Cited by 184
Hadzidimitriou, A., Agathangelidis, A., Darzentas, N., Murray, F., Delfau-Larue, M.-H., Pedersen, L. B., Lopez, A. N., Dagklis, A., Rombout, P., Beldjord, K., et al. (2011) · Blood · doi:10.1182/blood-2011-03-343434 · Cited by 181
Chng, W. J., Schop, R. F., Price-Troska, T., Ghobrial, I., Kay, N., Jelinek, D. F., Gertz, M. A., Dispenzieri, A., Lacy, M., Kyle, R. A., et al. (2006) · Blood · doi:10.1182/blood-2006-02-005488 · Cited by 180
Chen, L., Monti, S., Juszczynski, P., Ouyang, J., Chapuy, B., Neuberg, D., Doench, J. G., Bogusz, A. M., Habermann, T. M., Dogan, A., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.05.002 · Cited by 179
de Weers, M., Brouns, G. S., Hinshelwood, S., Kinnon, C., Schuurman, R. K., Hendriks, R. W., & Borst, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51014-6 · Cited by 178
Self-citationO'Rourke, L. M., Tooze, R., Turner, M., Sandoval, D. M., Carter, R. H., Tybulewicz, V. L. J., & Fearon, D. T. (1998) · Immunity · doi:10.1016/s1074-7613(00)80568-3 · Cited by 175
Hendriks, R. W., de Bruijn, M. F., Maas, A., Dingjan, G. M., Karis, A., & Grosveld, F. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00867.x · Cited by 174
Self-citationAdvances in the Biology and Treatment of Bone Disease in Multiple Myeloma
Raje, N., & Roodman, G. D. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1804 · Cited by 173
Weber, M., Treanor, B., Depoil, D., Shinohara, H., Harwood, N. E., Hikida, M., Kurosaki, T., & Batista, F. D. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072619 · Cited by 170
Wilson, W. H., Gerecitano, J. F., Goy, A., de Vos, S., Kenkre, V. P., Barr, P. M., Blum, K. A., Shustov, A. R., Advani, R. H., Lih, J., et al. (2012) · Blood · doi:10.1182/blood.v120.21.686.686 · Cited by 170
Tai, Y.-T., Chang, B. Y., Kong, S.-Y., Fulciniti, M., Yang, G., Calle, Y., Hu, Y., Lin, J., Zhao, J.-J., Cagnetta, A., et al. (2012) · Blood · doi:10.1182/blood-2011-12-396853 · Cited by 165
A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi
Hoogeboom, R., van Kessel, K. P. M., Hochstenbach, F., Wormhoudt, T. A., Reinten, R. J. A., Wagner, K., Kater, A. P., Guikema, J. E. J., Bende, R. J., & van Noesel, C. J. M. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121801 · Cited by 158
Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response
Lee, K.-G., Xu, S., Kang, Z.-H., Huo, J., Huang, M., Liu, D. X., Takeuchi, O., Akira, S., & Lam, K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119238109 · Cited by 150
MicroRNAs Prevent the Generation of Autoreactive Antibodies
Belver, L., de Yébenes, V. G., & Ramiro, A. R. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.010 · Cited by 148
Bruton's Tyrosine Kinase Is Essential for Human B Cell Tolerance
Ng, Y.-S., Wardemann, H., Chelnis, J. G., Cunningham‐Rundles, C., & Meffre, E. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040920 · Cited by 147
Vav3 Modulates B Cell Receptor Responses by Regulating Phosphoinositide 3-Kinase Activation
Inabe, K., Ishiai, M., Scharenberg, A. M., Freshney, N. W., Downward, J., & Kurosaki, T. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011571 · Cited by 146
Xu, D., Kim, Y. D., Postelnek, J., Vu, M. D., Hu, D., Liao, C., Bradshaw, M., Hsu, J., Zhang, J., Pashine, A., et al. (2012) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187740 · Cited by 143
Saito, K., Scharenberg, A. M., & Kinet, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100873200 · Cited by 140
Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia
Jumaa, H., Bossaller, L., Portugal, K., Storch, B., Lotz, M., Flemming, A., Schrappe, M., Postila, V., Riikonen, P. V., Pelkonen, J., et al. (2003) · Nature · doi:10.1038/nature01608 · Cited by 140
Cinar, M., Hamedani, F. S., Mo, Z., Cinar, B., Amin, H. M., & Alkan, S. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.07.028 · Cited by 136
Kurosaki, T., & Kurosaki, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15595 · Cited by 133
Sharma, S., Orlowski, G. M., & Song, W. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.182.1.329 · Cited by 132
Pleckstrin Homology Domains Interact with Filamentous Actin
Yao, L., Janmey, P. A., Frigeri, L. G., Han, W., Fujita, J., Kawakami, Y., Apgar, J. R., & Kawakami, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.28.19752 · Cited by 131
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia
Ngo, H. T., Leleu, X. P., Lee, J. Y., Jia, X., Melhem, M. R., Runnels, J. M., Moreau, A., Burwick, N. R., Azab, A. K., Roccaro, A. M., et al. (2008) · Blood · doi:10.1182/blood-2007-12-129395 · Cited by 130
CCL3 (MIP-1α) plasma levels and the risk for disease progression in chronic lymphocytic leukemia
Sivina, M., Hartmann, E., Kipps, T. J., Rassenti, L. Z., Krupnik, D., Lerner, S. A., LaPushin, R., Xiao, L., Huang, X., Werner, L. L., et al. (2010) · Blood · doi:10.1182/blood-2010-09-307249 · Cited by 127
Mechanism of B-Cell Receptor-Induced Phosphorylation and Activation of Phospholipase C-γ2
Kim, Y. J., Sekiya, F., Poulin, B., Bae, Y. S., & Rhee, S. G. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.22.9986-9999.2004 · Cited by 126
BLNK suppresses pre–B-cell leukemogenesis through inhibition of JAK3
Nakayama, J., Yamamoto, M., Hayashi, K., Satoh, H., Bundo, K., Kubo, M., Goitsuka, R., Farrar, M. A., & Kitamura, D. (2008) · Blood · doi:10.1182/blood-2008-07-166355 · Cited by 120
Kersseboom, R., Middendorp, S., Dingjan, G. M., Dahlenborg, K., Reth, M. G., Jumaa, H., & Hendriks, R. W. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030615 · Cited by 115
Self-citationSelective inhibition of BTK prevents murine lupus and antibody-mediated glomerulonephritis
Rankin, A. L., Seth, N., Keegan, S., Andreyeva, T., Cook, T. A., Edmonds, J., Mathialagan, N., Benson, M. J., Syed, J., Zhan, Y., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301553 · Cited by 113
Shinohara, H., Maeda, S., Watarai, H., & Kurosaki, T. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070379 · Cited by 111
Abe, M., Kido, S., Hiasa, M., Nakano, A., Oda, A., Amou, H., & Matsumoto, T. (2006) · Leukemia · doi:10.1038/sj.leu.2404228 · Cited by 109
The Tec Family Tyrosine Kinase Btk Regulates RANKL-induced Osteoclast Maturation
Lee, S. H., Kim, T. S., Jeong, D., Kim, N., & Choi, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708935200 · Cited by 106
Middendorp, S., Dingjan, G. M., Maas, A., Dahlenborg, K., & Hendriks, R. W. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5988 · Cited by 103
Self-citationYan, Q., Huang, Y., Watkins, J. A., Kocialkowski, S., Zeng, N., Hamoudi, R., Isaacson, P. G., de Leval, L., Wotherspoon, A. C., & Du, M. (2011) · Haematologica · doi:10.3324/haematol.2011.054080 · Cited by 99
Btk dosage determines sensitivity to B cell antigen receptor cross-linking
Satterthwaite, A. B., Cheroutre, H., Khan, W. N., Sideras, P., & Witte, O. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13152 · Cited by 99
N-linked glycosylation selectively regulates autonomous precursor BCR function
Übelhart, R., Bach, M. P., Eschbach, C., Wossning, T., Reth, M. G., & Jumaa, H. (2010) · Nature Immunology · doi:10.1038/ni.1903 · Cited by 96
Self-antigen recognition by follicular lymphoma B-cell receptors
Sachen, K. L., Strohman, M. J., Singletary, J., Alizadeh, A. A., Kattah, N. H., Lossos, C., Mellins, E., Levy, S., & Levy, R. (2012) · Blood · doi:10.1182/blood-2012-05-427534 · Cited by 94
The B‐cell antigen receptor signals through a preformed transducer module of SLP65 and CIN85
Oellerich, T., Bremes, V., Neumann, K., Bohnenberger, H., Dittmann, K., Hsiao, H., Engelke, M., Schnyder, T., Batista, F. D., Urlaub, H., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.251 · Cited by 92
Protein Profiling of Plasma Membranes Defines Aberrant Signaling Pathways in Mantle Cell Lymphoma
Boyd, R. S., Jukes‐Jones, R., Walewska, R. J., Brown, D., Dyer, M. J. S., & Cain, K. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800515-mcp200 · Cited by 91
Liu, L., Paolo, J. A. D., Barbosa, J., Rong, H., Reif, K., & Wong, H. H. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.181545 · Cited by 89
Nomura, K. T., Kanegane, H., Karasuyama, H., Tsukada, S., Agematsu, K., Murakami, G., Sakazume, S., Sako, M., Tanaka, R., Kuniya, Y., et al. (2000) · PubMed · Cited by 88
Impaired Precursor B Cell Differentiation in Bruton’s Tyrosine Kinase-Deficient Mice
Middendorp, S., Dingjan, G. M., & Hendriks, R. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.6.2695 · Cited by 88
Self-citationCritical function of Bmx/Etk in ischemia-mediated arteriogenesis and angiogenesis
He, Y. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28123 · Cited by 88
Kuehn, H. S., Rådinger, M., Brown, J. M., Ali, K., Vanhaesebroeck, B., Beaven, M. A., Metcalfe, D. D., & Gilfillan, A. M. (2010) · Journal of Cell Science · doi:10.1242/jcs.071043 · Cited by 87
Mina‐Osorio, P., LaStant, J., Keirstead, N. D., Whittard, T., Ayala, J., Stefanova, S., Garrido, R., Dimaano, N. M., Hilton, H., Giron, M., et al. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38047 · Cited by 84
Pighi, C., Gu, T., Dalai, I., Barbi, S., Parolini, C., Bertolaso, A., Pedron, S., Parisi, A., Ren, J., Cecconi, D., et al. (2011) · Cellular Oncology · doi:10.1007/s13402-011-0019-7 · Cited by 83
Conley, M. E., Parolini, O., Rohrer, J., & Campana, D. (1994) · Immunological Reviews · doi:10.1111/j.1600-065x.1994.tb00844.x · Cited by 80
The pre-BCR checkpoint as a cell-autonomous proliferation switch
Hendriks, R. W., & Middendorp, S. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.02.011 · Cited by 79
Self-citationProteasome-dependent autoregulation of Bruton tyrosine kinase (Btk) promoter via NF-κB
Yu, L., Mohamed, A. J., Simonson, O. E., Vargas, L., Blomberg, K. E. M., Björkstrand, B., Arteaga, H. J., Nore, B. F., & Smith, C. I. E. (2008) · Blood · doi:10.1182/blood-2007-10-121137 · Cited by 77
Liu, L., Halladay, J. S., Shin, Y. G., Wong, S., Coraggio, M., La, H., Baumgardner, M., Le, H. T., Gopaul, S., Boggs, J. W., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040840 · Cited by 74
Transgene Expression of bcl-xL Permits Anti-immunoglobulin (Ig)–induced Proliferation in xid B Cells
Solvason, N. W., Wu, W., Kabra, N. H., Lund‐Johansen, F., Roncarolo, M. G., Behrens, T. W., Grillot, D., Núñez, G., Lees, E. M., & Howard, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.7.1081 · Cited by 74
A novel isoform of the B cell tyrosine kinase BTK protects breast cancer cells from apoptosis
Eifert, C., Wang, X., Kokabee, L., Kourtidis, A., Jain, R., Gerdes, M. J., & Conklin, D. S. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22091 · Cited by 64
Kil, L. P., de Bruijn, M. J. W., van Hulst, J. A. C., Langerak, A. W., Yuvaraj, S., & Hendriks, R. W. (2013) · Europe PMC (PubMed Central) · Cited by 61
Self-citationJuszczyński, P., Chen, L., O'Donnell, E., Polo, J. M., Ranuncolo, S. M., Dalla‐Favera, R., Melnick, A. M., & Shipp, M. A. (2009) · Blood · doi:10.1182/blood-2009-02-204362 · Cited by 61
Dubovsky, J. A., Chappell, D. L., Harrington, B. K., Agrawal, K., Andritsos, L. A., Flynn, J. M., Jones, J. A., Paulaitis, M. E., Bolon, B. N., Johnson, A. J., et al. (2013) · Blood · doi:10.1182/blood-2013-05-504597 · Cited by 61
Kenny, E. F., Quinn, S. R., Doyle, S., Vink, P. M., van Eenennaam, H., & O'Neill, L. A. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074103 · Cited by 61
Biology and novel treatment options for XLA, the most common monogenetic immunodeficiency in man
Hendriks, R. W., Bredius, R. G. M., Pike‐Overzet, K., & Staal, F. J. T. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.585971 · Cited by 60
Self-citationDingjan, G. M., Maas, A., Nawijn, M. C., Smit, L., Voerman, J. S. A., Grosveld, F. G., & Hendriks, R. W. (1998) · The EMBO Journal · doi:10.1093/emboj/17.18.5309 · Cited by 60
Self-citationxid affects events leading to B cell cycle entry
Brorson, K., Brunswick, M., Ezhevsky, S. A., Wei, D. G., Berg, R., Scott, D. W., & Stein, K. E. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.1.135 · Cited by 59
Rajaiya, J., Nixon, J. C., Ayers, N., Desgranges, Z. P., Roy, A. L., & Webb, C. F. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02009-05 · Cited by 56
Marron, T. U., Martínez‐Gallo, M., Yu, J. E., & Cunningham‐Rundles, C. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.10.009 · Cited by 54
Burger, J. A., Keating, M. J., Wierda, W. G., Hoellenriegel, J., Ferrajoli, A., Faderl, S. H., Lerner, S. A., Zacharian, G., Huang, X., James, D. F., et al. (2012) · Blood · doi:10.1182/blood.v120.21.187.187 · Cited by 53
Hoogeboom, R., Wormhoudt, T. A. M., Schipperus, M. R., Langerak, A. W., Dunn‐Walters, D. K., Guikema, J. E. J., Bende, R. J., & van Noesel, C. J. M. (2012) · Leukemia · doi:10.1038/leu.2012.238 · Cited by 52
van Loo, P. F., Dingjan, G. M., Maas, A., & Hendriks, R. W. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.018 · Cited by 51
Self-citationTumor suppressor function of Bruton tyrosine kinase is independent of its catalytic activity
Middendorp, S., Zijlstra, A. J. E., Kersseboom, R., Dingjan, G. M., Jumaa, H., & Hendriks, R. W. (2004) · Blood · doi:10.1182/blood-2004-07-2708 · Cited by 51
Self-citationNisitani, S., Satterthwaite, A. B., Akashi, K., Weissman, I. L., Witte, O. N., & Wahl, M. I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050583597 · Cited by 50
BMX and Its Role in Inflammation, Cardiovascular Disease, and Cancer
Cenni, B., Gutmann, S., & Gottar, M. (2012) · International Reviews of Immunology · doi:10.3109/08830185.2012.663838 · Cited by 49
Lowry, W. E., & Huang, X. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110390200 · Cited by 39
Bao, H., Lu, P., Li, Y., Wang, L., Li, H., He, D., Yang, Y., Zhao, Y., Li, Y., Wang, M., et al. (2011) · Cancer Biology & Therapy · doi:10.4161/cbt.11.1.13878 · Cited by 38
Chang, B. Y., Furman, R. R., Zapatka, M., Barrientos, J. C., Li, D., Steggerda, S. M., Eckert, K., Francesco, M. R., Woyach, J. A., Johnson, A. J., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.31.15_suppl.7014 · Cited by 36
A mouse model for chronic lymphocytic leukemia based on expression of the SV40 large T antigen
ter Brugge, P. J., Ta, V. B. T., de Bruijn, M. J. W., Keijzers, G., Maas, A., van Gent, D. C., & Hendriks, R. W. (2009) · Blood · doi:10.1182/blood-2009-01-198937 · Cited by 33
Self-citationGustafsson, M. O., Hussain, A., Mohammad, D. K., Mohamed, A. J., Nguyen, V., Metalnikov, P. S., Colwill, K., Pawson, T. J., Smith, C. I. E., & Nore, B. F. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06620-11 · Cited by 28
Hirano, M., Kikuchi, Y., Nisitani, S., Yamaguchi, A., Satoh, A., Ito, T., Iba, H., & Takatsu, K. (2004) · International Immunology · doi:10.1093/intimm/dxh076 · Cited by 24
The Role of Tec Family Kinases in the Regulation of T-helper-cell Differentiation
Boucheron, N., & Ellmeier, W. (2012) · International Reviews of Immunology · doi:10.3109/08830185.2012.664798 · Cited by 22
The Role of B Cell Receptor Stimulation in CLL Pathogenesis
Kil, L. P., Yuvaraj, S., Langerak, A. W., & Hendriks, R. W. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212801227041 · Cited by 14
Self-citationHoerr, I. (2000) · doi:10.1002/1521-4141(200001)30:1
Cited by
Small molecules in targeted cancer therapy: advances, challenges, and future perspectives
Zhong, L., Li, Y., Xiong, L., Wang, W., Wu, M., Yuan, T., Yang, W., Tian, C., Miao, Z., Wang, T., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00572-w · Cited by 1,696
Molecular targeted therapy: Treating cancer with specificity
Lee, Y. T., Tan, Y. J., & Oon, C. E. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.07.034 · Cited by 1,067
FDA-approved small-molecule kinase inhibitors
Wu, P., Nielsen, T. E., & Clausen, M. H. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.005 · Cited by 1,013
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Gotwals, P., Cameron, S., Cipolletta, D., Cremasco, V., Crystal, A., Hewes, B., Mueller, B., Quaratino, S., Sabatos-Peyton, C., Petruzzelli, L., et al. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.17 · Cited by 953
Palucka, A. K., & Coussens, L. M. (2016) · Cell · doi:10.1016/j.cell.2016.01.049 · Cited by 843
Metadata
- Authors
- Hendriks, R. W., Yuvaraj, S., & Kil, L. P.
- Venue
- Nature Reviews Cancer
- Published
- 2014-03-24
- Volume
- 14
- Issue
- 4
- Pages
- 219-232
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1993345471
- Cited by
- 552
- References
- 155
- FWCI
- 8.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.